A new COVID-19 study is currently enrolling patients, and researchers believe it has the potential to change the course of the virus around the world.
The study is examining the effects of Colchicine, a widely available and inexpensive antiinflammatory drug on one of the most common, and most debilitating side effects of SARS-CoV-2–acute respiratory distress syndrome (ARDS).
ARDS is caused by…